Expanding Selection Criteria to Repairable Diseased Hearts to Meet the Demand of Shortage of Donors in Heart Transplantation.
donor heart
heart transplant
marginal hearts
organ donor shortage
prioritization
repairable hearts
selection criteria
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
May 2022
May 2022
Historique:
accepted:
29
05
2022
entrez:
6
6
2022
pubmed:
7
6
2022
medline:
7
6
2022
Statut:
epublish
Résumé
Heart transplant surgery is considered the destination therapy for end-stage heart disease. Unfortunately, many patients in the United States of America who are eligible candidates for transplants cannot undergo surgery due to donor shortage. In addition, some donors' hearts are being labeled as unacceptable for transplant surgery because of the rigorous and restricted rules placed on the approval process of using a donor's heart. Over the last few decades, the rising discrepancy between the scarcity of donor hearts and the demand for such organs has led to the discussion of expanding the donor heart selection criteria. A softer view on using marginal hearts for transplants would help those on the waitlist to receive a heart transplant. Marginal hearts that contain the hepatitis c virus (HCV), COVID-19, older age, or repairable heart defects have become viable options to use for a heart transplant. Also, the prioritization based on the new heart allocation system would help efficiently decide which recipients would be the first to get a donor's heart. Recently there has been a consensus to broaden the eligibility of donor's hearts by accepting valvular abnormalities, coronary artery disease, and congenital abnormalities. This review highlights some of those expansions in selection criteria in particular using repairable hearts, which could be fixed in the operating room on the back table before transplantation.
Identifiants
pubmed: 35663679
doi: 10.7759/cureus.25485
pmc: PMC9150717
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
e25485Informations de copyright
Copyright © 2022, Yazji et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Circ Heart Fail. 2021 Aug;14(8):e007433
pubmed: 34315226
Exp Gerontol. 2018 Sep;110:230-240
pubmed: 29935294
Ann Thorac Surg. 1994 Jan;57(1):76-81; discussion 81-2
pubmed: 8279923
Am J Transplant. 2020 Nov;20(11):3081-3088
pubmed: 32659028
Korean Circ J. 2018 Jul;48(7):565-590
pubmed: 29968430
Am J Transplant. 2012 Dec;12(12):3213-34
pubmed: 22974276
Circulation. 2013 Jan 1;127(1):e6-e245
pubmed: 23239837
J Heart Lung Transplant. 2004 Mar;23(3):277-83
pubmed: 15019636
JAMA. 2006 Oct 18;296(15):1843-50
pubmed: 17047214
J Heart Lung Transplant. 2014 Mar;33(3):261-9
pubmed: 24559944
J Heart Lung Transplant. 2016 May;35(5):547-9
pubmed: 27197770
Ann Thorac Surg. 2019 Oct;108(4):1133-1139
pubmed: 31178157
J Heart Lung Transplant. 2000 Sep;19(9):897-9
pubmed: 11008081
Eur J Cardiothorac Surg. 2005 Jul;28(1):143-8
pubmed: 15982597
J Thorac Cardiovasc Surg. 2002 Apr;123(4):810-5
pubmed: 11986611
J Heart Lung Transplant. 2016 Mar;35(3):362-369
pubmed: 26632028
Nat Rev Cardiol. 2011 Jan;8(1):30-41
pubmed: 21060326
J Heart Lung Transplant. 2010 Oct;29(10):1089-103
pubmed: 20870164
J Heart Lung Transplant. 2019 Nov;38(11):1178-1188
pubmed: 31492607
JACC Heart Fail. 2016 Sep;4(9):689-97
pubmed: 27179836
J Card Surg. 2021 Mar;36(3):1148-1149
pubmed: 33448478
J Heart Lung Transplant. 2009 Sep;28(9):981-3
pubmed: 19716055
Drugs Context. 2021 Dec 15;10:
pubmed: 34970319
J Heart Lung Transplant. 1999 Apr;18(4):310-9
pubmed: 10226895
J Heart Lung Transplant. 2005 Nov;24(11):1781-6
pubmed: 16297782
Arch Cardiovasc Dis. 2020 Nov;113(11):674-678
pubmed: 32868256
JAMA. 2004 Jul 21;292(3):344-50
pubmed: 15265849
Circulation. 2003 Apr 1;107(12):1692-711
pubmed: 12668507
Liver Int. 2016 Jan;36 Suppl 1:47-57
pubmed: 26725897
Transplant Proc. 2012 Jun;44(5):1385-9
pubmed: 22664020
Ann Thorac Surg. 2001 Sep;72(3):753-7
pubmed: 11565653
J Heart Lung Transplant. 2008 Sep;27(9):943-56
pubmed: 18765186
Clin Rev Allergy Immunol. 2014 Feb;46(1):54-64
pubmed: 23636734
Transplant Direct. 2020 Dec 15;7(1):e642
pubmed: 33335981
Circulation. 2002 Aug 13;106(7):836-41
pubmed: 12176957
Tex Heart Inst J. 2017 Apr 1;44(2):135-137
pubmed: 28461800
Infect Disord Drug Targets. 2020;20(2):143-149
pubmed: 30663575
Ann Thorac Surg. 2011 Aug;92(2):520-7; discussion 527
pubmed: 21683337
J Am Coll Cardiol. 2014 Apr 1;63(12):1169-1178
pubmed: 24462511
J Thorac Cardiovasc Surg. 2020 Sep 16;:
pubmed: 34756380
JAMA Cardiol. 2020 Feb 1;5(2):167-174
pubmed: 31851352
Curr Treat Options Cardiovasc Med. 2021;23(5):28
pubmed: 33776401
J Thorac Dis. 2014 Aug;6(8):1097-104
pubmed: 25132976
Exp Clin Transplant. 2022 Jan;20(1):12-18
pubmed: 35060444
Transpl Infect Dis. 2021 Apr;23(2):e13503
pubmed: 33174324
Circ Heart Fail. 2018 Apr;11(4):e004586
pubmed: 29666073
Transplant Proc. 2009 Apr;41(3):932-4
pubmed: 19376391
J Am Coll Cardiol. 2004 May 5;43(9):1562-4
pubmed: 15120812
Transplant Proc. 2001 Nov-Dec;33(7-8):3803-4
pubmed: 11750620
J Am Heart Assoc. 2021 Aug 3;10(15):e019655
pubmed: 34315285
Pain Med. 2018 Mar 1;19(3):485-490
pubmed: 28460060
Ann Thorac Surg. 2019 Jan;107(1):62-66
pubmed: 30172858
J Thorac Cardiovasc Surg. 2018 May;155(5):e151-e152
pubmed: 29305032